Published in AIDS Weekly, August 14th, 1995
Scientists at the Wellcome Research Laboratories in Kent, United Kingdom (U.K.), said that when AZT is taken with 3TC, the combination overcomes the problem of viral resistance that reduces the effectiveness of either drug taken alone.
In 24-week-long tests on patients infected with AIDS, the combination caused a drop in the amount of viral infection and a rise in the number of lymphocytes, called CD4 cells, that are the target of the virus.
CD4 cells protect the body from infection and it is their...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.